The State Regulatory Service supported proposals and comments on draft license conditions concerning pharmaceutical products manufacture, trade and import developed by Better Regulation Delivery Office (BRDO) experts and business representatives.
This was the subject of the SRS meeting, where the Cabinet of Ministers of Ukraine draft regulation “On approval of license conditions on economic activities in the pharmaceutical products manufacture, pharmaceutical products wholesale and retail selling, pharmaceutical products import (except Active Pharmaceutical Ingredients)” was discussed.
The BRDO Market Surveillance Sector Head Volodymyr Holovatenko and the BRDO expert Leonid Lytvynenko made their proposals and comments on the draft regulation developed together with business representatives during the roundtable organized by the BRDO.
“The SRS collaborates with experts and business representatives in the field of regulatory policy optimization. Such partnership of the state, experts and business representatives ensure the implementation of really efficient regulatory initiatives ensuring the balance of state and business interests”, Volodymyr Holovatenko says.
Although the work on the draft regulation has not finished yet, the most of questions, which required a mutual understanding between the SRS, experts and business representatives, have been solved. This effective cooperation will result in efficient license conditions that will assist in expanding the drugs range, their quality and best prices.
It is to be reminded that BRDO launched a special section on its website, where license conditions coming from the SRS and the Ministry of Economic Development and Trade will be published.
The Better Regulation Delivery Office calls business representatives and the public to join this process and send their proposals to [email protected]. All proposals and comments sent to the Better Regulation Delivery Office (BRDO) will be taken into account while preparing the conclusions.